Ola Fjellström

Human target validation of phosphoinositide 3‐kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor

Sven Nylander, Bengt Kull, Jan‐Arne Björkman et al. · Journal of Thrombosis and Haemostasis · 2012 · 122 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Analysis of Selective Regions in the Active Sites of Human Cytochromes P450, 2C8, 2C9, 2C18, and 2C19 Homology Models Using GRID/CPCA

Marianne Ridderström, Ismael Zamora, Ola Fjellström et al. · Journal of Medicinal Chemistry · 2001 · 70 citations

Pharmacy, Biochemistry, Pharmacology +17

Involvement of the metabolic sensor GPR81 in cardiovascular control

Kristina Wallenius, Pia Thalén, Jan‐Arne Björkman et al. · JCI Insight · 2017 · 59 citations · Full text

Life Sciences, Pharmacology, Physiology +17

Potent Fibrinolysis Inhibitor Discovered by Shape and Electrostatic Complementarity to the Drug Tranexamic Acid

Jonas Boström, Jennifer Grant, Ola Fjellström et al. · Journal of Medicinal Chemistry · 2013 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials

Javier Armisen, Mitra Rauschecker, Janeli Sarv et al. · Journal of Hepatology · 2025 · 53 citations

Life Sciences, Genetics, Molecular Genetics +4